146 related articles for article (PubMed ID: 11758501)
1. Aminosalicylate as prophylaxis for Crohn's disease.
Qasim A; Seery J; O'Morain CA
Gut; 2001 Dec; 49(6):873. PubMed ID: 11758501
[No Abstract] [Full Text] [Related]
2. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
3. Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there?
Sutherland LR
Gastroenterology; 2000 Feb; 118(2):436-8. PubMed ID: 10648473
[No Abstract] [Full Text] [Related]
4. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
Ford AC
Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
[No Abstract] [Full Text] [Related]
5. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Reinisch W; Stange EF;
Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
[No Abstract] [Full Text] [Related]
6. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Hayee BH; Harris AW
Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
[No Abstract] [Full Text] [Related]
7. 5-aminosalicylates to prevent relapse of Crohn's disease after surgery.
Doherty G; Moss AC
Am J Gastroenterol; 2012 Mar; 107(3):487; author reply 487-8. PubMed ID: 22388032
[No Abstract] [Full Text] [Related]
8. Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
D'Haens GR; Rutgeerts PJ
Acta Gastroenterol Belg; 1994; 57(5-6):311-3. PubMed ID: 7709700
[TBL] [Abstract][Full Text] [Related]
9. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
Bauer WM; Brzezinski A; Lashner BA
Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
Ardizzone S; Bollani S; Manzionna G; Colombo E; Maconi G; Imbesi V; Bianchi Porro G
Ann Ital Chir; 2003; 74(6):621-5. PubMed ID: 15206802
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
Karoui S; Kallel L; Boubaker J; Filali A
Tunis Med; 2006 Oct; 84(10):595-8. PubMed ID: 17193847
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
McLeod RS; Wolff BG; Ross S; Parkes R; McKenzie M;
Dis Colon Rectum; 2009 May; 52(5):919-27. PubMed ID: 19502857
[TBL] [Abstract][Full Text] [Related]
13. Medical therapy to reduce postoperative Crohn's disease recurrence.
Achkar JP; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
15. [Can the postoperative relapse of Crohn disease be influenced?].
Jussila A; Färkkilä M; Järvinen HJ
Duodecim; 2001; 117(8):817-22; quiz 822, 857. PubMed ID: 12116447
[No Abstract] [Full Text] [Related]
16. Prevention of postoperative recurrence of Crohn's disease.
van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
[TBL] [Abstract][Full Text] [Related]
17. Mesalamine and relapse prevention in Crohn's disease.
Cottone M; Cammà C
Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
[No Abstract] [Full Text] [Related]
18. Prevention of postoperative recurrence in Crohn's disease.
Terdiman JP
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):616-20. PubMed ID: 17967564
[No Abstract] [Full Text] [Related]
19. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.
Burisch J; Bergemalm D; Halfvarson J; Domislovic V; Krznaric Z; Goldis A; Dahlerup JF; Oksanen P; Collin P; de Castro L; Hernandez V; Turcan S; Belousova E; D'Incà R; Sartini A; Valpiani D; Giannotta M; Misra R; Arebi N; Duricova D; Bortlik M; Gatt K; Ellul P; Pedersen N; Kjeldsen J; Andersen KW; Andersen V; Katsanos KH; Christodoulou DK; Sebastian S; Barros L; Magro F; Midjord JM; Nielsen KR; Salupere R; Kievit HA; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Kaimakliotis IP; Schwartz D; Odes S; Lakatos L; Lakatos PL; Langholz E; Munkholm P;
United European Gastroenterol J; 2020 Oct; 8(8):949-960. PubMed ID: 32715989
[TBL] [Abstract][Full Text] [Related]
20. Interventions for prevention of post-operative recurrence of Crohn's disease.
Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC
Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
